These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 3107988

  • 1. Class 1B agents lidocaine, mexiletine, tocainide, phenytoin.
    Rizzon P, Di Biase M, Favale S, Visani L.
    Eur Heart J; 1987 Mar; 8 Suppl A():21-5. PubMed ID: 3107988
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tocainide and mexiletine. Orally effective lidocaine analogues.
    Roden DM.
    Arch Intern Med; 1985 Mar; 145(3):417-8. PubMed ID: 3919665
    [No Abstract] [Full Text] [Related]

  • 4. Class IB antiarrhythmic drugs: tocainide, mexiletine, and moricizine.
    Snyder DW.
    J La State Med Soc; 1989 May; 141(5):21-5. PubMed ID: 2499645
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease.
    Reiter MJ, Easley AR, Mann DE.
    Am J Cardiol; 1987 Jun 01; 59(15):1319-24. PubMed ID: 3109228
    [Abstract] [Full Text] [Related]

  • 9. Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II.
    Singh BN, Cho YW, Kuemmerle HP.
    Int J Clin Pharmacol Ther Toxicol; 1981 May 01; 19(5):185-99. PubMed ID: 6788721
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The role of antiarrhythmic drugs in prevention of sudden cardiac death.
    Podrid PJ.
    Cardiovasc Clin; 1985 May 01; 15(3):265-86. PubMed ID: 2421903
    [No Abstract] [Full Text] [Related]

  • 12. Therapy with investigational antiarrhythmic drugs.
    Mead RH, Harrison DC.
    Med Clin North Am; 1984 Sep 01; 68(5):1321-37. PubMed ID: 6436596
    [Abstract] [Full Text] [Related]

  • 13. Ventricular arrhythmias. An assessment of newer therapeutic agents.
    Skluth H, Grauer K, Gums J.
    Postgrad Med; 1989 May 01; 85(6):137-8, 141-8, 153. PubMed ID: 2496401
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical pharmacology of anti-arrhythymia agents. II. Lignocaine, mexiletine, tocainide, phenytoin].
    Witkowska M.
    Kardiol Pol; 1981 May 01; 24(11-12):803-13. PubMed ID: 6804681
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Drug therapy of arrhythmia in coronary cardiopathy].
    Lüderitz B.
    Clin Ter; 1983 Apr 15; 105(1):3-11. PubMed ID: 6189663
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. New drugs in the management of ventricular arrhythmias.
    Sanna GP.
    G Ital Cardiol; 1984 Oct 15; 14(10):788-97. PubMed ID: 6083894
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.